SUBSCRIBE
SUBSCRIBE
News   Business

Stryker Corporation Gets FDA Warning Letter for Ireland Plant

June 20, 2007 | 
1 min read
CHICAGO, June 19 (Reuters) - U.S. regulators sent Stryker Corp. a warning letter, saying the artificial hip and knee maker has not completed promised fixes at a plant in Ireland, according to a letter posted by regulators on Tuesday.
Real estate Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Man walking on a long wavy path with flag at the end, persistence, determination and ultimate business success - 3D Render
Rare disease
UniQure Eyes Phase 3 for Huntington’s Gene Therapy Despite Makary’s Apparent Criticism
March 2, 2026
 · 
3 min read
 · 
Heather McKenzie
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Cuts at Merck, Disc Leave Hundreds Jobless
March 2, 2026
 · 
60 min read
 · 
BioSpace Editorial Staff
Racing Cars at the finish line
Approvals
Ascendis Enters Achondroplasia Arena as FDA Approves First Weekly Drug
March 2, 2026
 · 
2 min read
 · 
Tristan Manalac
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: BMS, GSK, Aldeyra and More
March 2, 2026
 · 
4 min read
 · 
Tristan Manalac